281 related articles for article (PubMed ID: 36252537)
1. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma.
Mandal M; Banerjee I; Mandal M
Colloids Surf B Biointerfaces; 2022 Dec; 220():112899. PubMed ID: 36252537
[TBL] [Abstract][Full Text] [Related]
2. Management of retinoblastoma: opportunities and challenges.
Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
Drug Deliv; 2016 Sep; 23(7):2488-2496. PubMed ID: 25758593
[TBL] [Abstract][Full Text] [Related]
3. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.
Arshad R; Barani M; Rahdar A; Sargazi S; Cucchiarini M; Pandey S; Kang M
Biosensors (Basel); 2021 Mar; 11(4):. PubMed ID: 33810621
[TBL] [Abstract][Full Text] [Related]
4. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma.
Tabatabaei SN; Derbali RM; Yang C; Superstein R; Hamel P; Chain JL; Hardy P
J Control Release; 2019 Mar; 298():177-185. PubMed ID: 30776396
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles containing insoluble drug for cancer therapy.
Guo S; Huang L
Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
[TBL] [Abstract][Full Text] [Related]
7. New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Haase A; Miroschnikov N; Klein S; Doege A; Dünker N; Van Meenen D; Junker A; Göpferich A; Apaolaza PS; Busch MA
Mol Oncol; 2024 Apr; 18(4):832-849. PubMed ID: 38217258
[TBL] [Abstract][Full Text] [Related]
8. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses.
Doghish AS; Moustafa HAM; Elballal MS; Sarhan OM; Darwish SF; Elkalla WS; Mohammed OA; Atta AM; Abdelmaksoud NM; El-Mahdy HA; Ismail A; Abdel Mageed SS; Elrebehy MA; Abdelfatah AM; Abulsoud AI
Pathol Res Pract; 2023 Jul; 247():154537. PubMed ID: 37216745
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma and tumor-suppressor gene therapy.
Xu HJ
Ophthalmol Clin North Am; 2003 Dec; 16(4):621-9. PubMed ID: 14741002
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics.
Hu X; Zhang D; Huang L; Zeng Z; Su Y; Chen S; Lin X; Hong S
ACS Biomater Sci Eng; 2024 Mar; 10(3):1830-1842. PubMed ID: 38408449
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
12. The rb pathway and cancer therapeutics.
Du W; Searle JS
Curr Drug Targets; 2009 Jul; 10(7):581-9. PubMed ID: 19601762
[TBL] [Abstract][Full Text] [Related]
13. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
14. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics.
Sarkar M; Wang Y; Ekpenyong O; Liang D; Xie H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1846. PubMed ID: 35979879
[TBL] [Abstract][Full Text] [Related]
16. Application of gold nanoparticles in biomedical and drug delivery.
Daraee H; Eatemadi A; Abbasi E; Fekri Aval S; Kouhi M; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016; 44(1):410-22. PubMed ID: 25229833
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.
Narayana RVL; Jana P; Tomar N; Prabhu V; Nair RM; Manukonda R; Kaliki S; Coupland SE; Alexander J; Kalirai H; Kondapi AK; Vemuganti GK
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):13. PubMed ID: 34784412
[TBL] [Abstract][Full Text] [Related]
18. Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.
Manzari-Tavakoli A; Babajani A; Tavakoli MM; Safaeinejad F; Jafari A
Cancer Med; 2024 Mar; 13(5):e7010. PubMed ID: 38491817
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
